ABSTRACT
Because cancer registry data provide a census of cancer cases, registry data can be used to: 1) define and monitor cancer incidence at the local, state, and national levels; 2) investigate patterns of cancer treatment; and 3) evaluate the effectiveness of public health efforts to prevent cancer cases and improve cancer survival. The purpose of this article is to provide a broad overview of the history of cancer surveillance programs in the United States, and illustrate the expanding ways in which cancer surveillance data are being made available and contributing to cancer control programs. The article describes the building of the cancer registry infrastructure and the successful coordination of efforts among the 2 federal agencies that support cancer registry programs, the Centers for Disease Control and Prevention and the National Cancer Institute, and the North American Association of Central Cancer Registries. The major US cancer control programs also are described, including the National Comprehensive Cancer Control Program, the National Breast and Cervical Cancer Early Detection Program, and the Colorectal Cancer Control Program. This overview illustrates how cancer registry data can inform public health actions to reduce disparities in cancer outcomes and may be instructional for a variety of cancer control professionals in the United States and in other countries. Cancer 2017;123:4969-76. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.
Subject(s)
Neoplasms/epidemiology , Public Health Surveillance , Public Health/history , Registries , Centers for Disease Control and Prevention, U.S. , History, 20th Century , History, 21st Century , Humans , Neoplasms/prevention & control , Neoplasms/therapy , SEER Program/history , United States/epidemiologyABSTRACT
An historic perspective on the development of the National Cancer Institute's series of cancer atlases is provided. Emphasis is placed on the role which emergent questions concerning environmental determinants of cancer played in the acquisition and utilization of data resources. Studies which were fielded as a consequence of the atlases are highlighted. The legacy of the collective effort of many persons who worked on the development of the cancer atlases-the facilitation of many current epidemiologic investigations-is discussed.